Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
language:"English"
publishDate:"[2020 TO 2029]"
format_facet:"Aufsätze"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=language%3A%22English%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=language%3A%22English%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=language%3A%22English%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (649.340)
1
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments : Natural History Study of Albright Hereditary Osteodystrophy: Includes Substudies on Effects of Growth Hormone in Patients With Pseudohypoparathyroidism Type 1A and Cognitive & Behavioral Studies in Albright Hereditary Osteodystrophy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Clinical Trial of High Dose CoQ10 in ALS : Clinical Trial of High Dose CoQ10 in ALS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia : Phase II Study of 2-Chlorodeoxyadenosine (2CDA) Followed by Rituximab in Hairy Cell Leukemia
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer : A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome : The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome : A Phase 2 Study of Fludarabine, Cytarabine, Filgrastim-sndz,Gemtuzumab Ozogamicin and Idarubicin in Newly Diagnosed Core Binding Factor Associated Acute Myelogenous Leukemia
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7) : A Worldwide, Randomized, Double Blind, Placebo-Controlled, Parallel Group Clinical Trial to Evaluate the Safety and Efficacy of Rizatriptan for the Acute Treatment of Migraine in Children and Adolescents
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Clinical Trial of West-China Perioperative Transfusion Score (WCPTS)for Massive Hemorrhagic Surgery : A Randomized Controlled Clinical Trial of Transfusion Under the Guidance of West-China Perioperative Transfusion Score(WCPTS)for Massive Hemorrhagic Surgery
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors : Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors. A 24-week Open-label, Proof-of-concept Pilot Clinical Trial.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment : An Open-Label Extension of Study HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Intrathecal Idursulfase-IT Administered in Conjunction With Intravenous Elaprase® in Pediatric Patients With Hunter Syndrome and Cognitive Impairment
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[64934]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Sprache: Englisch
Filter aufheben
Erscheinungsjahr: 2020-2029
Filter aufheben
Medienart: Aufsätze
Medienart
Aufsätze
649.340
E-Artikel
649.340
E-Ressourcen
Zeitschriftentitel
437.410
WHO International Clinical Trials Registry Plat...
211.930
ClinicalTrials.gov
Thema
649.340
610
648.376
Study Type: Interventional
171.368
Recruitment Status: Completed
166.438
Recruitment Status: Recruiting
164.956
Recruitment Status: Not yet recruiting
79.045
Phase: Phase 3
78.479
Phase: Phase 2
46.116
Recruitment Status: Complete: follow-up complete
35.509
Phase: Phase 1
34.980
Recruitment Status: Authorised-recruitment may ...
33.764
Phase: Phase 4
23.170
Recruitment Status: Active, not recruiting
11.784
Recruitment Status: Terminated
10.616
Phase: Phase 2/Phase 3
8.514
Phase: Phase 1/Phase 2
7.483
Phase: Phase 1, Phase 2
7.236
Recruitment Status: Complete: follow-up continuing
6.099
Recruitment Status: Withdrawn
5.189
Breast Neoplasms
5.170
Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-
51.565
2024
174.660
2023
191.008
2022
137.023
2021
95.084
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Englisch
Haven't found what you're looking for?
Wird geladen...